Document Type : Review Article


1 Molecular Pathology and Cytogenetics Division, Pathology Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

2 Cell-Based Therapies Research Center, Digestive Disease Research Institute, Shari'ati Hospital, Tehran University of Medical Science, Tehran, Iran

3 Pathology and Stem Cells Research Center, Kerman University of Medical Sciences, Kerman, Iran


From the beginning of the COVID-19 epidemic, clinical laboratories around the world have been involved with tests for detection of SARS-CoV-2. Currently, RT-PCR (real-time reverse transcription polymerase chain reaction assay) is the gold standard for identifying the virus. Many factors are involved in achieving the highest accuracy in this test, including parameters related to the pre-analysis stage. Having instructions on the type of sample, how to take the sample, and its storage and transportation help control the interfering factors at this stage. Studies have shown that pre-analytical factors might be the cause of the high SARS-CoV-2 test false-negative rates. Also, the safety of personnel in molecular laboratories is of utmost importance, and it requires strict guidelines to ensure the safety of exposed individuals and prevent the virus from spreading. Since the onset of the outbreak, various instructions and guidelines have been developed in this field by the institutions and the Ministry of Health of each country; these guidelines are seriously in need of integration and operation. In this study, we try to collect all the information and research done from the beginning of this pandemic in December 2019- August 2022 concerning biosafety and protective measures, sample types, sampling methods, container and storage solutions, sampling equipment, and sample storage and transportation for molecular testing of SARS-CoV-2.


Main Subjects

  1. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, et al. Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020;40(5):351-60. [PMID] [PMCID] [DOI:10.3343/alm.2020.40.5.351]
  2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-207. [PMID] [PMCID] [DOI:10.1056/NEJMoa2001316]
  3. Jerving S. The long road ahead for COVID-19 vaccination in Africa. Lancet (London, England). 2021;398(10303):827-8. [DOI:10.1016/S0140-6736(21)01967-X]
  4. Nyaruaba R, Mwaliko C, Hong W, Amoth P, Wei H. SARS-CoV-2/COVID-19 Laboratory Biosafety Practices and Current Molecular Diagnostic Tools. Int. J Biosaf Biosecurity. 2021. [PMID] [PMCID] [DOI:10.1016/j.jobb.2021.10.001]
  5. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. [DOI:10.1186/s40779-020-00240-0] [PMID] [PMCID]
  6. La Marca A, Capuzzo M, Paglia T, Roli L, Trenti T, Nelson SM. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reprod Biomed Online. 2020;41(3):483-99. [PMID] [PMCID] [DOI:10.1016/j.rbmo.2020.06.001]
  7. Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3):313-24. [DOI:10.4014/jmb.2003.03011] [PMID] [PMCID]
  8. Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020;58(7):1070-6. [DOI:10.1515/cclm-2020-0285] [PMID]
  9. Payne D, Newton D, Evans P, Osman H, Baretto R. Preanalytical issues affecting the diagnosis of COVID-19. J Clin Pathol. 2021;74(4):207-8. [DOI:10.1136/jclinpath-2020-206751] [PMID]
  10. Tan SS, Yan B, Saw S, Lee CK, Chong AT, Jureen R, et al. Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore. J Clin Pathol. 2021;74(4):257-60. [DOI:10.1136/jclinpath-2020-206563] [PMID]
  11. Kojima N, Turner F, Slepnev V, Bacelar A, Deming L, Kodeboyina S, Klausner JD. October 2020. Self-collected oral fluid and nasal swab specimens demonstrate comparable sensitivity to clinician-collected nasopharyngeal swab specimens for the detection of SARS-CoV-2. Clin Infect. 2021;73(9):e3106-e9. [DOI:10.1093/cid/ciaa1589] [PMID] [PMCID]
  12. Chadaga K, Chakraborty C, Prabhu S, Umakanth S, Bhat V, Sampathila N. Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning. Interdiscip. Sci. 2022;14(2):452-70. [PMID] [PMCID] [DOI:10.1007/s12539-021-00499-4]
  13. Hong KH, Kim GJ, Roh KH, Sung H, Lee J, Kim SY, et al. Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea. Ann Lab Med. 2022;42(4):391-7. [DOI:10.3343/alm.2022.42.4.391] [PMID] [PMCID]
  14. Kukull B, Shakir SM, Hanson KE. Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2. Clin Lab Med. 2022;42(2):249-59. [DOI:10.1016/j.cll.2022.02.002] [PMID] [PMCID]
  15. Caruana G, Croxatto A, Coste AT, Opota O, Lamoth F, Jaton K, et al. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clin Microbiol Infect. 2020;26(9):1178-82. [DOI:10.1016/j.cmi.2020.06.019] [PMID] [PMCID]
  16. Stanoeva KR, van der Eijk AA, Meijer A, Kortbeek LM, Koopmans MPG, Reusken C. Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies. Euro Commun Dis Bulletin. 2021;26(10). [DOI:10.2807/1560-7917.ES.2021.26.10.2001134]
  17. Zhang Y, Cen M, Hu M, Du L, Hu W, Kim JJ, et al. Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients With COVID-19 Infection: A Systematic Review and Meta-analysis. Clinical Transl Gastroenterol. 2021;12(4):e00343. [PMCID] [DOI:10.14309/ctg.0000000000000343] [PMID]
  18. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9. [DOI:10.1038/s41586-020-2196-x] [PMID]
  19. Rong G, Zheng Y, Chen Y, Zhang Y, Zhu P, Sawan M. COVID-19 diagnostic methods and detection techniques: a review. Ref Modul Biomed Sci.2021:B978-0-12-822548-6.00080-7. [DOI:10.1016/B978-0-12-822548-6.00080-7] [PMCID]
  20. World Health Organization. (‎2020)‎. Laboratory testing for coronavirus disease (‎COVID-19)‎ in suspected human cases: interim guidance, 19 March 2020. World Health Organization. https :// 0665/331501.
  21. Hanson KE, Altayar O, Caliendo AM, Arias CA, Englund JA, Hayden MK, et al. The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing. Clinical Infect Dis. 2021. [DOI:10.1093/cid/ciab557] [PMID]
  22. Sutjipto S, Lee PH, Tay JY, Mendis SM, Abdad MY, Marimuthu K, et al. The Effect of Sample Site, Illness Duration, and the Presence of Pneumonia on the Detection of SARS-CoV-2 by Real-time Reverse Transcription PCR. Open Forum Infect Dis. 2020;7(9):ofaa335. [DOI:10.1093/ofid/ofaa335] [PMID] [PMCID]
  23. Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv. 2020. [DOI:10.1101/2020.02.11.20021493]
  24. Chen X, Xia S. Sensitive methods for detection of SARS-CoV-2 RNA. Methods Microbiol. 2022;50:1-26. Epub 2021. [DOI:10.1016/bs.mim.2021.06.001] [PMCID]
  25. Péré H, Podglajen I, Wack M, Flamarion E, Mirault T, Goudot G, et al. Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage. J Clin Microbiol. 2020;58(6). [DOI:10.1128/JCM.00721-20] [PMID] [PMCID]
  26. Lim J, Lee J. Current laboratory diagnosis of coronavirus disease 2019. Korean J Intern Med. 2020;35(4):741-8. [DOI:10.3904/kjim.2020.257] [PMID] [PMCID]
  27. Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerging microbes & infections. 2020;9(1):747-56. [DOI:10.1080/22221751.2020.1745095] [PMID] [PMCID]
  28. Miranda-Ortiz H, Fernández-Figueroa EA, Ruíz-García EB, Muñoz-Rivas A, Méndez-Pérez A, Méndez-Galván J, et al. Development of an alternative saliva test for diagnosis of SARS-CoV-2 using TRIzol: Adapting to countries with lower incomes looking for a large-scale detection program. PloS One. 2021;16(8):e0255807. [DOI:10.1371/journal.pone.0255807] [PMID] [PMCID]
  29. Premraj A, Aleyas AG, Nautiyal B, Rasool TJ. Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls. Diagnostics (Basel, Switzerland). 2020;10(11). [PMID] [PMCID] [DOI:10.3390/diagnostics10110866]
  30. Banada P, Elson D, Daivaa N, Park C, Desind S, Montalvan I, et al. Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing. J Med Microbiol. 2021;70(9). [DOI:10.1099/jmm.0.001380] [PMID] [PMCID]
  31. Cockerill FR, Wohlgemuth JG, Radcliff J, Sabol CE, Kapoor H, Dlott JS, et al. Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease. Population Health Manag. 2021;24(S1):S26-s34. [DOI:10.1089/pop.2020.0296] [PMID] [PMCID]
  32. Rasool G, Riaz M, Abbas M, Fatima H, Qamar MM, Zafar F, et al. COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review. Int J Immunopathol Pharmacol. 2022;36:3946320221115316. [PMID] [PMCID] [DOI:10.1177/03946320221115316]
  33. Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert J, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Public Health. 2020;5(8):e452-e9. [DOI:10.1016/S2468-2667(20)30157-2] [PMID]
  34. Grassly NC, Pons-Salort M, Parker EPK, White PJ, Ferguson NM. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. Lancet Infect Dis. 2020;20(12):1381-9. [DOI:10.1016/S1473-3099(20)30630-7] [PMID]
  35. Humphreys DP, Gavin KM, Olds KM, Bonaca MP, Bauer TA. At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers. BMC Infect Dis. 2022;22(1):443. [DOI:10.1186/s12879-022-07377-4] [PMID] [PMCID]
  36. Karthik K, Aravindh Babu RP, Dhama K, Chitra MA, Kalaiselvi G, Alagesan Senthilkumar TM, et al. Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis. Arch Med Res. 2020;51(7):623-30. [DOI:10.1016/j.arcmed.2020.08.007] [PMID] [PMCID]
  37. Callahan C, Lee R, Lee G, Zulauf KE, Kirby JE, Arnaout R. Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads. medRxiv. 2020. [DOI:10.1101/2020.06.12.20128736]
  38. Hiebert NM, Chen BA, Sowerby LJ. Variability in instructions for performance of nasopharyngeal swabs across Canada in the era of COVID-19 - what type of swab is actually being performed? J otolaryngology - Head Neck Surg. 2021;50(1):5. [PMCID] [DOI:10.1186/s40463-020-00490-x] [PMID]
  39. Lee RA, Herigon JC, Benedetti A, Pollock NR, Denkinger CM. Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis. J Clin Microbiol. 2021;59(5). [DOI:10.1128/JCM.02881-20] [PMID] [PMCID]
  40. Lee S, Widyasari K, Yang HR, Jang J, Kang T, Kim S. Evaluation of the Diagnostic Accuracy of Nasal Cavity and Nasopharyngeal Swab Specimens for SARS-CoV-2 Detection via Rapid Antigen Test According to Specimen Collection Timing and Viral Load. Diagnostics (Basel, Switzerland). 2022;12(3). [PMID] [PMCID] [DOI:10.3390/diagnostics12030710]
  41. Patriquin G, LeBlanc JJ, Williams C, Hatchette TF, Ross J, Barrett L, et al. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer. Microbiol Spectr. 2022;10(1):e0245521. [PMCID] [DOI:10.1128/spectrum.02455-21] [PMID]
  42. Kim DH, Kim D, Moon JW, Chae SW, Rhyu IJ. Complications of Nasopharyngeal Swabs and Safe Procedures for COVID-19 Testing Based on Anatomical Knowledge. J Korean Med Sci. 2022;37(11):e88. [DOI:10.3346/jkms.2022.37.e88] [PMID] [PMCID]
  43. Rodrigues J, Gouveia C, Santos MA, Costa O, Côrte-Real R, Brito MJ. Comparison of nasopharyngeal samples for SARS-CoV-2 detection in a paediatric cohort. J Pediatr Child Health. 2021;57(7):1078-81. [DOI:10.1111/jpc.15405] [PMID] [PMCID]
  44. Garnett L, Bello A, Tran KN, Audet J, Leung A, Schiffman Z, et al. Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages. J Virol Methods. 2020;285:113947. [PMID] [PMCID] [DOI:10.1016/j.jviromet.2020.113947]
  45. Pondaven-Letourmy S, Alvin F, Boumghit Y, Simon F. How to perform a nasopharyngeal swab in adults and children in the COVID-19 era. Euro Ann Otorhinolaryngol Head Neck Dis. 2020;137(4):325-7. [DOI:10.1016/j.anorl.2020.06.001] [PMID] [PMCID]
  46. Kaufman AC, Brewster R, Rajasekaran K. How to Perform a Nasopharyngeal Swab - An Otolaryngology Perspective. Am J Med. 2020;133(11):1280-2. [DOI:10.1016/j.amjmed.2020.05.004] [PMID] [PMCID]
  47. Petruzzi G, De Virgilio A, Pichi B, Mazzola F, Zocchi J, Mercante G, et al. COVID-19: Nasal and oropharyngeal swab. Head Neck. 2020;42(6):1303-4. [DOI:10.1002/hed.26212] [PMID] [PMCID]
  48. Hitzenbichler F, Bauernfeind S, Salzberger B, Schmidt B, Wenzel JJ. Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2. Viruses. 2021;13(4). [DOI:10.3390/v13040653] [PMID] [PMCID]
  49. Teo AKJ, Choudhury Y, Tan IB, Cher CY, Chew SH, Wan ZY, et al. Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection. Sci Rep. 2021;11(1):3134. [DOI:10.1038/s41598-021-82787-z] [PMID] [PMCID]
  50. Williams E, Bond K, Zhang B, Putland M, Williamson DA. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2. J Clin Microbiol. 2020;58(8). [DOI:10.1128/JCM.00776-20] [PMID] [PMCID]
  51. Manabe YC, Reuland C, Yu T, Azamfirei R, Hardick JP, Church T, et al. Self-Collected Oral Fluid Saliva Is Insensitive Compared With Nasal-Oropharyngeal Swabs in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Outpatients. Open Forum Infect Dis. 2021;8(2):ofaa648. [DOI:10.1093/ofid/ofaa648] [PMID] [PMCID]
  52. Tu Y, Jennings R, Hart B, Cangelosi G, Wood R, Wehber K, et al. Patient-collected tongue, nasal, and mid-turbinate swabs for SARS-CoV-2 yield equivalent sensitivity to health care worker collected nasopharyngeal swabs. MedRxiv. 2020:2020.04.01.20050005. [DOI:10.1101/2020.04.01.20050005]
  53. D'Andrea EL, Cossu AM, Scrima M, Messina V, Iuliano P, Di Perna F, et al. Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19). Viruses. 2021;13(8). [DOI:10.3390/v13081663] [PMID] [PMCID]
  54. Jamal AJ, Mozafarihashjin M, Coomes E, Anceva-Sami S, Barati S, Crowl G, et al. Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infect Control Hospital Epidemiol. 2021;42(8):1001-3. [DOI:10.1017/ice.2020.1326] [PMID] [PMCID]
  55. Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. MedRxiv. 2020.
  56. Azzi L, Maurino V, Baj A, Dani M, d'Aiuto A, Fasano M, et al. Diagnostic Salivary Tests for SARS-CoV-2. J Dental Res. 2021;100(2):115-23. [PMCID] [DOI:10.1177/0022034520969670] [PMID]
  57. Ana Laura GO, Abraham Josué NR, Briceida LM, Israel PO, Tania AF, Nancy MR, et al. Sensitivity of the Molecular Test in Saliva for Detection of COVID-19 in Pediatric Patients With Concurrent Conditions. Front Pediatr. 2021;9:642781[PMID] [PMCID]. [DOI:10.3389/fped.2021.642781]
  58. DeFina SM, Wang J, Yang L, Zhou H, Adams J, Cushing W, et al. SaliVISION: a rapid saliva-based COVID-19 screening and diagnostic test with high sensitivity and specificity. Sci Rep. 2022;12(1):5729. [PMCID] [DOI:10.1038/s41598-022-09718-4] [PMID]
  59. Thwe PM, Ren P. Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system. Diagn Microbiol Infect Dis. 2021;99(1):115228. [DOI:10.1016/j.diagmicrobio.2020.115228] [PMID] [PMCID]
  60. Lin C, Xiang J, Yan M, Li H, Huang S, Shen C. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19). Clin Chem Lab Med. 2020;58(7):1089-94. [DOI:10.1515/cclm-2020-0187] [PMID]
  61. Han H, Luo Q, Mo F, Long L, Zheng W. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients. The Lancet Infect Dis. 2020;20(6):655-6. [DOI:10.1016/S1473-3099(20)30174-2] [PMID]
  62. Saleem SM, Bhattacharya S. Sputum Testing as the New Mass Screening Method for COVID-19 Patients in India - A Public Health Perspective. Int J Prevent Med. 2022;13:86.
  63. Fujimoto D, Fukuya M, Terao S, Irei I, Akiyama T, Watanabe A, et al. Sputum characteristics of patients with severe COVID-19: report of two cases with immunocytochemical detection of SARS-CoV-2 spike protein. Med Molecul Morphol. 2022:1-7. [DOI:10.1007/s00795-022-00326-9] [PMID] [PMCID]
  64. Khiabani K, Amirzade-Iranaq MH. Are saliva and deep throat sputum as reliable as common respiratory specimens for SARS-CoV-2 detection? A systematic review and meta-analysis. Am J Infect Control. 2021;49(9):1165-76. [DOI:10.1016/j.ajic.2021.03.008] [PMID] [PMCID]
  65. Chiem C, Alghamdi K, Nguyen T, Han JH, Huo H, Jackson D. The impact of COVID-19 on blood transfusion services: a systematic review and meta-analysis. Transfus Med Hemother. 2022;49(2):107-18. [DOI:10.1159/000519245] [PMID] [PMCID]
  66. Xiao D, John Ling KH, Tarnowski T, Humeniuk R, German P, Mathias A, et al. Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies. Anal Biochem. 2021;617:114118. [DOI:10.1016/j.ab.2021.114118] [PMID] [PMCID]
  67. Hogan CA, Stevens BA, Sahoo MK, Huang C, Garamani N, Gombar S, et al. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clin Infect Dis. 2021;72(9):e291-e5. [DOI:10.1093/cid/ciaa1054] [PMID] [PMCID]
  68. Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, et al. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol. 2020;92(9):1676-80. [DOI:10.1002/jmv.25936] [PMID] [PMCID]
  69. Thudium RF, Stoico MP, Høgdall E, Høgh J, Krarup HB, Larsen MAH, et al. Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein. J Clin Microbiol. 2021;59(10):e0100121. [DOI:10.1128/JCM.01001-21] [PMID] [PMCID]
  70. Ludolf F, Ramos FF, Bagno FF, Oliveira-da-Silva JA, Reis TAR, Christodoulides M, et al. Detecting anti-SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion. Sci Adv. 2022;8(19):eabn7424. [DOI:10.1126/sciadv.abn7424] [PMID] [PMCID]
  71. García-Bernalt Diego J, Fernández-Soto P, Muñoz-Bellido JL, Febrer-Sendra B, Crego-Vicente B, Carbonell C, et al. Detection of SARS-CoV-2 RNA in Urine by RT-LAMP: A Very Rare Finding. J Clin Med. 2021;11(1). [DOI:10.3390/jcm11010158] [PMID] [PMCID]
  72. Nomoto H, Ishikane M, Katagiri D, Kinoshita N, Nagashima M, Sadamasu K, et al. Cautious handling of urine from moderate to severe COVID-19 patients. Am J Infect Control. 2020;48(8):969-71. [PMID] [PMCID] [DOI:10.1016/j.ajic.2020.05.034]
  73. Wang Y, Chen X, Wang F, Geng J, Liu B, Han F. Value of anal swabs for SARS-COV-2 detection: a literature review. Int J Med Sci. 2021;18(11):2389-93. [DOI:10.7150/ijms.59382] [PMID] [PMCID]
  74. Jung SH, Kim SW, Lee H, Oh JH, Lim J. Serial Screening for SARS-CoV-2 in Rectal Swabs of Symptomatic COVID-19 Patients. J Korean Med Sci. 2021;36(44):e301. [PMID] [PMCID] [DOI:10.3346/jkms.2021.36.e301]
  75. Sun M, Guo D, Zhang J, Zhang J, Teng HF, Xia J, et al. Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients. Future Microbiol. 2020;15:1101-7. [DOI:10.2217/fmb-2020-0090] [PMID] [PMCID]
  76. Ng SC, Chan FKL, Chan PKS. Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification. Lancet Gastroenterol Hepatol. 2020;5(7):642-3. [DOI:10.1016/S2468-1253(20)30124-2] [PMID]
  77. Tu YP, O'Leary TJ. Testing for Severe Acute Respiratory Syndrome-Coronavirus 2: Challenges in Getting Good Specimens, Choosing the Right Test, and Interpreting the Results. Crit Care Med. 2020;48(11):1680-9. [DOI:10.1097/CCM.0000000000004594] [PMID] [PMCID]
  78. Wu J, Liu J, Li S, Peng Z, Xiao Z, Wang X, et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel Med Infect Dis. 2020;37:101673. [PMID] [PMCID] [DOI:10.1016/j.tmaid.2020.101673]
  79. Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Netw Open. 2020;3(5):e208292. [DOI:10.1001/jamanetworkopen.2020.8292] [PMID] [PMCID]
  80. Temiz MZ, Dincer MM, Hacibey I, Yazar RO, Celik C, Kucuk SH, et al. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study. Andrologia. 2021;53(2):e13912. [DOI:10.1111/and.13912] [PMID] [PMCID]
  81. Delaroche L, Bertine M, Oger P, Descamps D, Damond F, Genauzeau E, et al. Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection. PloS One. 2021;16(12):e0260187. [PMID] [PMCID] [DOI:10.1371/journal.pone.0260187]
  82. Saylam B, Uguz M, Yarpuzlu M, Efesoy O, Akbay E, Çayan S. The presence of SARS-CoV-2 virus in semen samples of patients with COVID-19 pneumonia. Andrologia. 2021;53(8):e14145. [DOI:10.1111/and.14145] [PMID] [PMCID]
  83. Petronio Petronio G, Di Marco R, Costagliola C. Do Ocular Fluids Represent a Transmission Route of SARS-CoV-2 Infection? Front Med. 2020;7:620412. [DOI:10.3389/fmed.2020.620412] [PMID] [PMCID]
  84. Hada M, Khilnani K, Vyas N, Chouhan JK, Dharawat KS, Bhandari S, et al. Evaluating the presence of SARS-CoV-2 in the intraocular fluid of COVID-19 patients. Indian J Ophthalmol. 2021;69(9):2503-6. [DOI:10.4103/ijo.IJO_820_21] [PMID] [PMCID]
  85. Zhong Y, Wang K, Zhu Y, Lyu D, Yu Y, Li S, et al. Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis. Travel Med Infect Dis. 2021;44:102191[PMID] [PMCID]. [DOI:10.1016/j.tmaid.2021.102191]
  86. Xia R, Hsu Lin L, Sun W, Moreira AL, Simsir A, Brandler TC. Effusion fluid cytology and COVID-19 infection. Cancer Cytopathol. 2022;130(3):183-8. [DOI:10.1002/cncy.22545] [PMID] [PMCID]
  87. Lewis A, Frontera J, Placantonakis DG, Lighter J, Galetta S, Balcer L, et al. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci. 2021;421:117316. [DOI:10.1016/j.jns.2021.117316] [PMID] [PMCID]
  88. d'Aleo F, Arghittu M, Bandi C, Conte M, Creti R, Farina C. Guidance to post-mortem collection and storage of biological specimens for the diagnosis of Covid-19 infection. Microbiol Med. 2020;35(2). [DOI:10.4081/mm.2020.9191]
  89. Centres for Disease Control and Prevention. Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19, March 2020(Interim Guidance). Available from: / guidance-postmortem-specimens.
  90. Basso C, Calabrese F, Sbaraglia M, Del Vecchio C, Carretta G, Saieva A, et al. Feasibility of postmortem examination in the era of COVID-19 pandemic: the experience of a Northeast Italy University Hospital. Int J Pathol. 2020;477(3):341-7. [DOI:10.1007/s00428-020-02861-1] [PMID] [PMCID]
  91. Al-Abdely HM, Midgley CM, Alkhamis AM, Abedi GR, Lu X, Binder AM, et al. Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia. Emerg Infect Dis. 2019;25(4):753-66. [DOI:10.3201/eid2504.181595] [PMID] [PMCID]
  92. Mølhave M, Agergaard J, Wejse C. Clinical Management of COVID-19 Patients - An Update. Seminars Nuclear Med. 2022;52(1):4-10. [PMID] [PMCID] [DOI:10.1053/j.semnuclmed.2021.06.004]
  93. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature Med. 2020;26(5):672-5. [DOI:10.1038/s41591-020-0869-5] [PMID]
  94. Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med 2020;173(4):262-7. [DOI:10.7326/M20-1495] [PMID] [PMCID]
  95. Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL, et al. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020;382(24):2302-15. [PMID] [PMCID] [DOI:10.1056/NEJMoa2006100]
  96. Radbel J, Jagpal S, Roy J, Brooks A, Tischfield J, Sheldon M, et al. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium. J. Mol. Diagn. 2020;22(7):871-5. [DOI:10.1016/j.jmoldx.2020.04.209] [PMID] [PMCID]
  97. Rodino KG, Espy MJ, Buckwalter SP, Walchak RC, Germer JJ, Fernholz E, et al. Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing. J Clin Microbiol. 2020;58(6). [DOI:10.1128/JCM.00590-20] [PMID] [PMCID]
  98. Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. J Clin Microbiol. 2020;58(6). [DOI:10.1128/JCM.00512-20] [PMID] [PMCID]
  99. Coronavirus disease 2019 (COVID-19) caused by a Novel Coronavirus (SARS-CoV-2) Guidelines for case-finding, diagnosis, and public health response in South Africa. Updated 25-06- 2020.
  100. Malentacchi F, Pazzagli M, Simi L, Orlando C, Wyrich R, Günther K, et al. SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. PloS One. 2014;9(11):e112293. [PMID] [PMCID] [DOI:10.1371/journal.pone.0112293]
  101. Habibi N, Behbehani M, Uddin S, Al-Salameen F, Shajan A, Zakir F. A safe and effective sample collection method for assessment of SARS-CoV-2 in aerosol samples. InEnvironmental resilience and transformation in times of COVID-19 2021 Jan 1 (pp. 173-178). Elsevier. [DOI:10.1016/B978-0-323-85512-9.00016-4] [PMCID]
  102. Majam M, Msolomba V, Scott L, Stevens W, Marange F, Kahamba T, et al. Self-Sampling for SARS-CoV-2 Diagnostic Testing by Using Nasal and Saliva Specimens: Protocol for Usability and Clinical Evaluation. JMIR Res Protoc. 2021;10(5):e24811.
  103. Naeem W, Zeb H, Rashid MI. Laboratory biosafety measures of SARS-CoV-2 at containment level 2 with particular reference to its more infective variants. Biosaf Health. 2022;4(1):11-4. [PMID] [PMCID] [DOI:10.1016/j.bsheal.2021.12.005]
  104. Bain W, Lee JS, Watson AM, Stitt-Fischer MS. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens. Curr Protoc Cytom. 2020;93(1):e77. [DOI:10.1002/cpcy.77] [PMID] [PMCID]